My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 165

    1.

    Actions of N-arachidonyl-glycine in a rat inflammatory pain model.

    Succar R, Mitchell VA, Vaughan CW.

    Mol Pain. 2007 Aug 30;3:24.PMID: 17727733 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Actions of N-arachidonyl-glycine in a rat neuropathic pain model.

    Vuong LA, Mitchell VA, Vaughan CW.

    Neuropharmacology. 2008 Jan;54(1):189-93. Epub 2007 May 18.PMID: 17588618 [PubMed - indexed for MEDLINE]Related articles

    3.

    Activation of peripheral cannabinoid CB1 and CB2 receptors suppresses the maintenance of inflammatory nociception: a comparative analysis.

    Gutierrez T, Farthing JN, Zvonok AM, Makriyannis A, Hohmann AG.

    Br J Pharmacol. 2007 Jan;150(2):153-63. Epub 2006 Dec 11.PMID: 17160008 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models.

    Jayamanne A, Greenwood R, Mitchell VA, Aslan S, Piomelli D, Vaughan CW.

    Br J Pharmacol. 2006 Feb;147(3):281-8.PMID: 16331291 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Actions of the endocannabinoid transport inhibitor AM404 in neuropathic and inflammatory pain models.

    Mitchell VA, Greenwood R, Jayamanne A, Vaughan CW.

    Clin Exp Pharmacol Physiol. 2007 Nov;34(11):1186-90.PMID: 17880375 [PubMed - indexed for MEDLINE]Related articles

    6.

    Selective activation of cannabinoid CB(2) receptors suppresses spinal fos protein expression and pain behavior in a rat model of inflammation.

    Nackley AG, Makriyannis A, Hohmann AG.

    Neuroscience. 2003;119(3):747-57.PMID: 12809695 [PubMed - indexed for MEDLINE]Related articles

    7.

    Cannabinoid modulation of cutaneous Adelta nociceptors during inflammation.

    Potenzieri C, Brink TS, Pacharinsak C, Simone DA.

    J Neurophysiol. 2008 Nov;100(5):2794-806. Epub 2008 Sep 10.PMID: 18784270 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Inhibition of inflammatory hyperalgesia by activation of peripheral CB2 cannabinoid receptors.

    Quartilho A, Mata HP, Ibrahim MM, Vanderah TW, Porreca F, Makriyannis A, Malan TP Jr.

    Anesthesiology. 2003 Oct;99(4):955-60.PMID: 14508331 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Endogenous anandamide and cannabinoid receptor-2 contribute to electroacupuncture analgesia in rats.

    Chen L, Zhang J, Li F, Qiu Y, Wang L, Li YH, Shi J, Pan HL, Li M.

    J Pain. 2009 Jul;10(7):732-9. Epub 2009 May 5.PMID: 19409856 [PubMed - indexed for MEDLINE]Related articles

    10.

    A role for cannabinoid receptors, but not endogenous opioids, in the antinociceptive activity of the CB2-selective agonist, GW405833.

    Whiteside GT, Gottshall SL, Boulet JM, Chaffer SM, Harrison JE, Pearson MS, Turchin PI, Mark L, Garrison AE, Valenzano KJ.

    Eur J Pharmacol. 2005 Dec 28;528(1-3):65-72. Epub 2005 Nov 28.PMID: 16316650 [PubMed - indexed for MEDLINE]Related articles

    11.

    Modulation of neuropathic and inflammatory pain by the endocannabinoid transport inhibitor AM404 [N-(4-hydroxyphenyl)-eicosa-5,8,11,14-tetraenamide].

    La Rana G, Russo R, Campolongo P, Bortolato M, Mangieri RA, Cuomo V, Iacono A, Raso GM, Meli R, Piomelli D, Calignano A.

    J Pharmacol Exp Ther. 2006 Jun;317(3):1365-71. Epub 2006 Mar 1.PMID: 16510698 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    The mu-opioid receptor agonist morphine, but not agonists at delta- or kappa-opioid receptors, induces peripheral antinociception mediated by cannabinoid receptors.

    da Fonseca Pacheco D, Klein A, de Castro Perez A, da Fonseca Pacheco CM, de Francischi JN, Duarte ID.

    Br J Pharmacol. 2008 Jul;154(5):1143-9. Epub 2008 May 12.PMID: 18469844 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Pharmacological and pharmacokinetic characterization of the cannabinoid receptor 2 agonist, GW405833, utilizing rodent models of acute and chronic pain, anxiety, ataxia and catalepsy.

    Valenzano KJ, Tafesse L, Lee G, Harrison JE, Boulet JM, Gottshall SL, Mark L, Pearson MS, Miller W, Shan S, Rabadi L, Rotshteyn Y, Chaffer SM, Turchin PI, Elsemore DA, Toth M, Koetzner L, Whiteside GT.

    Neuropharmacology. 2005 Apr;48(5):658-72.PMID: 15814101 [PubMed - indexed for MEDLINE]Related articles

    14.

    Effect of CP55,940 on mechanosensory spinal neurons following chronic inflammation.

    Choong KC, Su X, Urban MO.

    Neurosci Lett. 2007 Mar 6;414(2):105-9. Epub 2006 Dec 27.PMID: 17194542 [PubMed - indexed for MEDLINE]Related articles

    15.

    Effect of the cannabinoid ajulemic acid on rat models of neuropathic and inflammatory pain.

    Mitchell VA, Aslan S, Safaei R, Vaughan CW.

    Neurosci Lett. 2005 Jul 15;382(3):231-5. Epub 2005 Apr 8.PMID: 15925096 [PubMed - indexed for MEDLINE]Related articles

    16.

    Subunit-specific modulation of glycine receptors by cannabinoids and N-arachidonyl-glycine.

    Yang Z, Aubrey KR, Alroy I, Harvey RJ, Vandenberg RJ, Lynch JW.

    Biochem Pharmacol. 2008 Oct 15;76(8):1014-23. Epub 2008 Aug 7.PMID: 18755158 [PubMed - indexed for MEDLINE]Related articles

    17.
    18.

    Differential effects of cannabinoid receptor agonists on regional brain activity using pharmacological MRI.

    Chin CL, Tovcimak AE, Hradil VP, Seifert TR, Hollingsworth PR, Chandran P, Zhu CZ, Gauvin D, Pai M, Wetter J, Hsieh GC, Honore P, Frost JM, Dart MJ, Meyer MD, Yao BB, Cox BF, Fox GB.

    Br J Pharmacol. 2008 Jan;153(2):367-79. Epub 2007 Oct 29.PMID: 17965748 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Antinociceptive effects of the non-selective cannabinoid receptor agonist CP 55,940 are absent in CB1(-/-) and not CB2(-/-) mice in models of acute and persistent pain.

    Sain NM, Liang A, Kane SA, Urban MO.

    Neuropharmacology. 2009 Sep;57(3):235-41. Epub 2009 Jun 16.PMID: 19538975 [PubMed - indexed for MEDLINE]Related articles

    20.

    Effects of (S)-3,4-DCPG, an mGlu8 receptor agonist, on inflammatory and neuropathic pain in mice.

    Marabese I, de Novellis V, Palazzo E, Scafuro MA, Vita D, Rossi F, Maione S.

    Neuropharmacology. 2007 Feb;52(2):253-62. Epub 2006 Nov 17.PMID: 17113112 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination
    Write to the Help Desk